Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Abstract Background Weekly paclitaxel + ramucirumab (wPTX + RAM) therapy is recommended as the standard second-line chemotherapy regimen for unresectable advanced/recurrent gastric cancer (GC) or esophagogastric junction cancer. Recent subgroup analysis of the RAINBOW trial revealed a higher frequen...

Bibliográfalaš dieđut
Váldodahkkit:	Katsuhiko Nara, Takehito Yamamoto, Hiroharu Yamashita, Koichi Yagi, Tappei Takada, Yasuyuki Seto, Hiroshi Suzuki
Materiálatiipa:	Artihkal
Giella:	English
Almmustuhtton:	BMC 2023-10-01
Ráidu:	BMC Cancer
Fáttát:	Weekly paclitaxel + ramucirumab Febrile neutropenia Oxaliplatin Total bilirubin Gastric/Esophagogastric cancer
Liŋkkat:	https://doi.org/10.1186/s12885-023-11469-y

Geahča maid

Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Dahkki: Keita Miura, et al.
Almmustuhtton: (2024-02-01)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
Dahkki: Kosuke Hamai, et al.
Almmustuhtton: (2023-04-01)

How I treat febrile neutropenia
Dahkki: Marcio Nucci
Almmustuhtton: (2021-02-01)

Prediction of esophagogastric varices associated with oxaliplatin administration
Dahkki: Yosuke Satta, et al.
Almmustuhtton: (2021-11-01)

La neutropenia
Dahkki: Efraín Pulla Cadmilema, et al.
Almmustuhtton: (2023-08-01)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
Dahkki: Doaa Naeem, et al.
Almmustuhtton: (2018-08-01)

Febrile Neutropenia Due To Brucellosis: Case Report
Dahkki: Abdullah Sakin, et al.
Almmustuhtton: (2012-06-01)

Il costo di una neutropenia febbrile
Dahkki: C. Lucioni, et al.
Almmustuhtton: (2005-03-01)

Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
Dahkki: Sang Ngoc Nguyen, et al.
Almmustuhtton: (2022-08-01)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
Dahkki: Maria Bachlitzanaki, et al.
Almmustuhtton: (2023-10-01)

Voriconazole in Prevention and Treatment of Febrile Neutropenia
Dahkki: Hamidreza Taghva Masoumi, et al.
Almmustuhtton: (2018-02-01)

Febrile Neutropenia in Intensive Care Unit
Dahkki: Nattamol Hosiriluck, et al.
Almmustuhtton: (2015-07-01)

Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
Dahkki: Dessalegn M, et al.
Almmustuhtton: (2023-02-01)

Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
Dahkki: Razan Zatarah, et al.
Almmustuhtton: (2022-10-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
Dahkki: Müge ASLAN, et al.
Almmustuhtton: (2014-12-01)

The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia
Dahkki: Hüsamettin Vatansev, et al.
Almmustuhtton: (2023-03-01)

Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
Dahkki: Naoki Takahashi, et al.
Almmustuhtton: (2023-08-01)

Chemotherapy limiting neutropenia. Is prevention required?
Dahkki: I. B. Kononenko, et al.
Almmustuhtton: (2022-01-01)

New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
Dahkki: Ghidini M, et al.
Almmustuhtton: (2016-06-01)

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH
Dahkki: Marcio Nucci, et al.
Almmustuhtton: (2024-12-01)

Secondary Infections in Cancer Patients with Febrile Neutropenia
Dahkki: Alpay Azap, et al.
Almmustuhtton: (2012-08-01)

Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children
Dahkki: Morgan JE, et al.
Almmustuhtton: (2021-03-01)

The risk factors for febrile neutropenia during chemotherapy in children with malignancy
Dahkki: Rini Sulviani, et al.
Almmustuhtton: (2007-05-01)

Febrile neutropenia in childhood leukemia: Manado experience 1997 - 2006
Dahkki: Stefanus Gunawan, et al.
Almmustuhtton: (2009-12-01)

Thrombin generation in children with febrile neutropenia
Dahkki: Ayça Koca Yozgat, et al.
Almmustuhtton: (2021-04-01)

Clozapine-Induced Febrile Neutropenia and Cellulitis
Dahkki: Selcuk YAYLACI, et al.
Almmustuhtton: (2014-03-01)

Caracterización de los pacientes que ingresan a UCIP por neutropenia febril Clínica Prevenir Barranquilla 2015 –2016
Dahkki: Malvin Medina Caicedo
Almmustuhtton: (2017-12-01)

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Dahkki: Sylvie Lorenzen, et al.
Almmustuhtton: (2023-06-01)

Prevalencia de gérmenes con multirresistencia antibiótica en bacteriemia asociada a neutropenia febril en pacientes oncológicos hospitalizados
Dahkki: Carlos Soliz Poveda, et al.
Almmustuhtton: (2022-08-01)

Mortalidad de Pacientes Oncológicos vinculados a Neutropenia
Dahkki: Carlos García Cruz, et al.
Almmustuhtton: (2019-04-01)

Bundle for the prevention and management of complications of neutropenia in cancer patients
Dahkki: Rosilene Aparecida Costa Amaral, et al.

Doente com Neutropenia Febril: Uma Intervenção Especializada – Revisão Integrativa da Literatura
Dahkki: Cristina Santos, et al.
Almmustuhtton: (2021-06-01)

Risk factors associated with sepsis in children with acute lymphoblastic leukemia and febrile neutropenia
Dahkki: An nieza Dea Versary, et al.
Almmustuhtton: (2024-06-01)

Febrile neutropenia management in pediatric onco-hematologic patients: a systematic review
Dahkki: Tatiane Bertella, et al.
Almmustuhtton: (2021-10-01)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
Dahkki: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
Almmustuhtton: (2020-10-01)

Analyse of Febrile Neutropenia Attacks in Children with Acute Lymphoblastic Leukemia
Dahkki: Meriban Karadoğan, et al.
Almmustuhtton: (2023-09-01)

Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia
Dahkki: Keegan Peter Janssens, et al.
Almmustuhtton: (2021-05-01)

EVALUATION OF ANTIBIOTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH FEBRILE NEUTROPENIA
Dahkki: Ambar Yunita Nugraheni, et al.
Almmustuhtton: (2020-04-01)

Etiología bacteriana y susceptibilidad antibiótica en adultos con leucemias agudas y neutropenia febril con factores de alto riesgo
Dahkki: Jonathan Darío Ortega Calderón, et al.
Almmustuhtton: (2021-04-01)

Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
Dahkki: Vinson James, et al.
Almmustuhtton: (2021-06-01)